Cover Image
Market Research Report
Product code
1014724

Rituximab Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Growth And Change

Published: | The Business Research Company | 229 Pages | Delivery time: 2-3 business days

Price

Back to Top
Rituximab Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Growth And Change
Published: June 16, 2021
The Business Research Company
Content info: 229 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

Rituximab Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Growth And Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global rituximab biosimilar market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the rituximab biosimilar? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Rituximab biosimilar market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider rituximab biosimilar market, and compares it with other markets.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives brief overview and summary of the report.

Report Structure - This section gives the structure of the report and the information covered in various sections.

Introduction - This section gives the segmentation of the rituximab biosimilars market by geography, by drug type, by application and by route of administration covered in this report.

Market Characteristics - The market characteristics section of the report defines and explains the rituximab biosimilars market. This chapter includes different products and services covered in the report and basic definitions.

Trends And Strategies - This chapter includes some of the major trends shaping the global rituximab biosimilars market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Impact Of COVID-19 - This chapter describes the impact of COVID-19 on the rituximab biosimilars industry.

Global Market Size And Growth - This section contains the global historic (2015-2020) and forecast (2020-2025) market value, and drivers and restraints that support and control the growth of the market in the historic and forecast period.

Regional Analysis - This section contains the historic (2015-2020), forecast (2020-2025) market value and growth and market share comparison by region.

Segmentation- This section contains the market value (2015-20) and analysis for different segments.

Regional Market Size and Growth - This section contains the region's market size (2020), historic (2015-2020) and forecast (2020-2025) market value, and growth and market share comparison of major countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape - This section covers details on the competitive landscape of the global rituximab biosimilars market, estimated market shares and company profiles for the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Opportunities And Strategies - This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for rituximab biosimilars companies in terms of product offerings, geographic expansion, price offerings, and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered: 1) By Application: Non-hodgkin's lymphoma; Chronic lymphocytic leukemia; Rheumatoid arthriti; Others

2) By Distribution Channel: Hospital pharmacy; Mail order; Retail pharmacy

Companies Mentioned: Teva/Cellitron; Novartis AG; Pfizer; BIOCAD; Shanghai Henluis Biotech Inc.

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; United States

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, rituximab biosimilar indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents
Product Code: o&s247

Table of Contents

1. Rituximab Biosimilars Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Application
    • 6.1.3. Segmentation By Distribution Channel

7. Rituximab Biosimilars Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Application
    • 7.2.1. Non-Hodgkin's Lymphoma
    • 7.2.2. Chronic Lymphocytic Leukemia
    • 7.2.3. Rheumatoid Arthritis
    • 7.2.4. Others
  • 7.3. Market Segmentation By Distribution Channel
    • 7.3.1. Retail Pharmacy
    • 7.3.2. Hospital Pharmacy
    • 7.3.3. Mail Order

8. Rituximab Biosimilars Market Trends And Strategies

  • 8.1. Revised FDA Regulations To Facilitate Biosimilar Drug Development
  • 8.2. Large Number Of Strategic Partnerships and Collaborations.
  • 8.3. Robust Research & Development

9. Impact Of COVID-19 On The Rituximab Biosimilars Market

  • 9.1. Impact On The Global Rituximab Biosimilars Market
  • 9.2. How Leading Rituximab Biosimilars Companies Handled COVID

10. Global Rituximab Biosimilars Market Size And Growth

  • 10.1. Market Size
  • 10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
    • 10.2.1. Drivers Of The Market 2015 - 2020
    • 10.2.2. Restraints On The Market 2015 - 2020
  • 10.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
    • 10.3.1. Drivers Of The Market 2020 - 2025
    • 10.3.2. Restraints On The Market 2020 - 2025

11. Global Rituximab Biosimilars Market Segmentation

  • 11.1. Global Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 11.1.1. Non-Hodgkin's Lymphoma
    • 11.1.2. Chronic Lymphocytic Leukemia
    • 11.1.3. Rheumatoid Arthritis
    • 11.1.4. Others
  • 11.2. Global Rituximab Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 11.2.1. Hospital Pharmacy
    • 11.2.2. Retail Pharmacies
    • 11.2.3. Mail Order

12. Rituximab Biosimilars Market, Regional And Country Analysis

  • 12.1. Global Rituximab Biosimilars Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 12.2. Global Rituximab Biosimilars Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Rituximab Biosimilars Market

  • 13.1. Asia-Pacific Rituximab Biosimilars Market Overview
    • 13.1.1. Region Information
    • 13.1.2. Market Information
    • 13.1.3. COVID-19 Impact
    • 13.1.4. Background Information
    • 13.1.5. Government Initiatives
    • 13.1.6. Regulations
    • 13.1.7. Regulatory Bodies
    • 13.1.8. Major Associations
    • 13.1.9. Taxes Levied
    • 13.1.10. Corporate Tax Structure
    • 13.1.11. Investments
    • 13.1.12. Major Companies
  • 13.2. Asia-Pacific Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.3. Asia-Pacific Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.4. Asia-Pacific Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.5. Asia-Pacific Rituximab Biosimilars Market: Country Analysis
  • 13.6. China Rituximab Biosimilars Market
  • 13.7. China Rituximab Biosimilars Market Overview
  • 13.8. China Rituximab Biosimilars Market Overview
    • 13.8.1. Country Information
    • 13.8.2. Market Information
    • 13.8.3. COVID-19 Impact
    • 13.8.4. Background information
    • 13.8.5. Government Initiatives
    • 13.8.6. Regulations
    • 13.8.7. Regulatory Bodies
    • 13.8.8. Major Associations
    • 13.8.9. Taxes levied
    • 13.8.10. Corporate tax structure
    • 13.8.11. Investments
    • 13.8.12. Major Companies
  • 13.9. China Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.10. China Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.11. China Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.12. India Rituximab Biosimilars Market
  • 13.13. India Rituximab Biosimilars Market Overview
    • 13.13.1. Country Information
    • 13.13.2. Market Information
    • 13.13.3. COVID-19 Impact
    • 13.13.4. Background Information
    • 13.13.5. Government Initiatives
    • 13.13.6. Regulations
    • 13.13.7. Regulatory Bodies
    • 13.13.8. Major Associations
    • 13.13.9. Taxes Levied
    • 13.13.10. Corporate Tax Structure
    • 13.13.11. Investments
    • 13.13.12. Major Companies
  • 13.14. India Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.15. India Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.16. India Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.17. Japan Rituximab Biosimilars Market
  • 13.18. Japan Rituximab Biosimilars Market Overview
    • 13.18.1. Country Information
    • 13.18.2. Market Information
    • 13.18.3. COVID-19 Impact
    • 13.18.4. Background Information
    • 13.18.5. Government Initiatives
    • 13.18.6. Regulations
    • 13.18.7. Regulatory Bodies
    • 13.18.8. Major Associations
    • 13.18.9. Taxes Levied
    • 13.18.10. Corporate Tax Structure
    • 13.18.11. Investments
    • 13.18.12. Major Companies
  • 13.19. Japan Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.20. Japan Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.21. Japan Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.22. Australia Rituximab Biosimilars Market
  • 13.23. Australia Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.24. Australia Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.25. Australia Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.26. Indonesia Rituximab Biosimilars Market
  • 13.27. Indonesia Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.28. Indonesia Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.29. South Korea Rituximab Biosimilars Market
  • 13.30. South Korea Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.31. South Korea Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.32. South Korea Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe Rituximab Biosimilars Market

  • 14.1. Western Europe Rituximab Biosimilars Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Market Information
    • 14.1.3. COVID-19 Impact
    • 14.1.4. Background Information
    • 14.1.5. Government Initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes Levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investments
    • 14.1.12. Major Companies
  • 14.2. Western Europe Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.3. Western Europe Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.4. Western Europe Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.5. Western Europe Rituximab Biosimilars Market: Country Analysis
  • 14.6. UK Rituximab Biosimilars Market
  • 14.7. UK Rituximab Biosimilars Market Overview
    • 14.7.1. Country Information
    • 14.7.2. Market Information
    • 14.7.3. COVID-19 Impact
    • 14.7.4. Background Information
    • 14.7.5. Government Initiatives
    • 14.7.6. Regulations
    • 14.7.7. Regulatory Bodies
    • 14.7.8. Major Associations
    • 14.7.9. Taxes Levied
    • 14.7.10. Corporate Tax Structure
    • 14.7.11. Investments
    • 14.7.12. Major Companies
  • 14.8. UK Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.9. UK Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.10. UK Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.11. Germany Rituximab Biosimilars Market
  • 14.12. Germany Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.13. Germany Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.14. Germany Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.15. France Rituximab Biosimilars Market
  • 14.16. France Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.17. France Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.18. France Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Rituximab Biosimilars Market

  • 15.1. Eastern Europe Rituximab Biosimilars Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Market Information
    • 15.1.3. COVID-19 Impact
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Associations
    • 15.1.9. Taxes levied
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investment
    • 15.1.12. Major Companies
  • 15.2. Eastern Europe Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 15.3. Eastern Europe Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 15.4. Eastern Europe Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.5. Eastern Europe Rituximab Biosimilars Market: Country Analysis
  • 15.6. Russia Rituximab Biosimilars Market
  • 15.7. Russia Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 15.8. Russia Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 15.9. Russia Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

16. North America Rituximab Biosimilars Market

  • 16.1. North America Rituximab Biosimilars Market Overview
    • 16.1.1. Region Information
    • 16.1.2. Market Information
    • 16.1.3. COVID 19 Impact
    • 16.1.4. Background Information
    • 16.1.5. Government Initiatives
    • 16.1.6. Regulations
    • 16.1.7. Regulatory Bodies
    • 16.1.8. Major Associations
    • 16.1.9. Taxes Levied
    • 16.1.10. Corporate Tax Structure
    • 16.1.11. Investments
    • 16.1.12. Major Companies
  • 16.2. North America Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 16.3. North America Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 16.4. North America Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 16.5. North America Rituximab Biosimilars Market: Country Analysis
  • 16.6. USA Rituximab Biosimilars Market
  • 16.7. USA Rituximab Biosimilars Market Overview
    • 16.7.1. Country Information
    • 16.7.2. Market Information
    • 16.7.3. COVID 19 Impact
    • 16.7.4. Background Information
    • 16.7.5. Government Initiatives
    • 16.7.6. Regulations
    • 16.7.7. Regulatory Bodies
    • 16.7.8. Major Associations
    • 16.7.9. Tax Levied
    • 16.7.10. Corporate Tax Structure
    • 16.7.11. Investments
    • 16.7.12. Major Companies
  • 16.8. USA Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 16.9. USA Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 16.10. USA Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

17. South America Rituximab Biosimilars Market

  • 17.1. South America Rituximab Biosimilars Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. COVID-19 Impact
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. South America Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.3. South America Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.4. South America Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.5. South America Rituximab Biosimilars Market: Country Analysis
  • 17.6. Brazil Rituximab Biosimilars Market
  • 17.7. Brazil Rituximab Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.8. Brazil Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.9. Brazil Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

18. Middle East Rituximab Biosimilars Market

  • 18.1. Middle East Rituximab Biosimilars Market Overview
    • 18.1.1. Region Information
    • 18.1.2. COVID 19 impact
    • 18.1.3. Background Information
    • 18.1.4. Government Initiatives
    • 18.1.5. Regulations
    • 18.1.6. Regulatory Bodies
    • 18.1.7. Major Associations
    • 18.1.8. Taxes Levied
    • 18.1.9. Corporate Tax Structure
    • 18.1.10. Investments
    • 18.1.11. Major Companies
  • 18.2. Middle East Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.3. Middle East Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Africa Rituximab Biosimilars Market

  • 19.1. Africa Rituximab Biosimilars Market Overview
    • 19.1.1. Region Information
    • 19.1.2. COVID-19 impact
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulations
    • 19.1.6. Regulatory Bodies
    • 19.1.7. Associations
    • 19.1.8. Taxes levied
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Major Companies
  • 19.2. Africa Rituximab Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.3. Africa Rituximab Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. Global Rituximab Biosimilars Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. Teva Pharmaceuticals
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. Novartis AG
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Financial Overview
  • 20.4. Pfizer
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Business Strategy
    • 20.4.4. Financial overview
  • 20.5. BIOCAD
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial Overview
  • 20.6. Shanghai Henlius Biotech, Inc.
    • 20.6.1. Company Overview
    • 20.6.2. Products And Services
    • 20.6.3. Business Strategy
    • 20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Rituximab Biosimilars Market

  • 21.1. Innovent Biologics And Eli Lilly and Company Collaboration
  • 21.2. Teva Pharmaceuticals And Celltrion Healthcare Jointly Launched TRUXIMA
  • 21.3. Coherus Biosciences Acquired Rights From Innovent Biologics
  • 21.4. Ibio, Inc. Collaborated With CC-Pharming Ltd.
  • 21.5. Torrent Pharmaceuticals Collaborated with Reliance Life Sciences
  • 21.6. Forty Seven Inc. Collaborated With Acerta Pharma
  • 21.7. Sanofi Partnered with JHL Biotech

22. Rituximab Biosimilars Market

  • 22.1. Global Rituximab Biosimilars Market In 2025 - Countries Offering Most New Opportunities
  • 22.2. Global Rituximab Biosimilars Market In 2025 - Segments Offering Most New Opportunities
  • 22.3. Global Rituximab Biosimilars Market In 2025 - Growth Strategies
    • 22.3.1. Market Trend Based Strategies
    • 22.3.2. Competitor Strategies

23. Rituximab Biosimilars, Conclusions And Recommendations

  • 23.1. Conclusions
  • 23.2. Recommendations
    • 23.2.1. Product
    • 23.2.2. Place
    • 23.2.3. Price
    • 23.2.4. Promotion
    • 23.2.5. People

24. Appendix

  • 24.1. Market Data Sources
  • 24.2. Research Methodology
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company
  • 24.6. Copyright and Disclaimer